Cleared Special

K023048 - MODIFICATION TO SYNCHRON SYSTEMS BENZODIAZEPINE REAGENT (FDA 510(k) Clearance)

Nov 2002
Decision
55d
Days
Class 2
Risk

K023048 is an FDA 510(k) clearance for the MODIFICATION TO SYNCHRON SYSTEMS BENZODIAZEPINE REAGENT. This device is classified as a Enzyme Immunoassay, Benzodiazepine (Class II - Special Controls, product code JXM).

Submitted by Beckman Coulter, Inc. (Brea, US). The FDA issued a Cleared decision on November 7, 2002, 55 days after receiving the submission on September 13, 2002.

This device falls under the Toxicology FDA review panel. Regulated under 21 CFR 862.3170.

Submission Details

510(k) Number K023048 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 13, 2002
Decision Date November 07, 2002
Days to Decision 55 days
Submission Type Special
Review Panel Toxicology (TX)
Summary Summary PDF

Device Classification

Product Code JXM — Enzyme Immunoassay, Benzodiazepine
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.3170

Similar Devices — JXM Enzyme Immunoassay, Benzodiazepine

All 7
Alinity c Benzodiazepines Reagent Kit
K243498 · Microgenics Corporation · Dec 2024
ONLINE DAT Benzodiazepines II
K221765 · Roche Diagnostics · Dec 2022
CEDIA Benzodiazepine Assay
K190968 · Microgenics Corporation · Dec 2019
DRI Benzodiazepine Assay
K173963 · Microgenics Corporation · Feb 2018
Healgen Multi-Drug Urine Test Cup
K163704 · Healgen Scientific, LLC · Aug 2017
Healgen Multi-Drug Urine Test Cup, Healgen Multi-Drug Urine Test Dip Card
K153597 · Healgen Scientific, LLC · May 2016